人脑源性神经营养因子cDNA在COS7细胞中的表达及活性研究

本文从质粒Ｍ１３ｍｐ１８－ｈＢＤＮＦ中酶切回收人脑源性神经营养因子（ｈＢＤＮＦ）全长基因,构建真核表达载体ｐＣＭＶ４－ｈＢＤＮＦ。利用脂质体的方法转染ＣＯＳ７细胞,对转染后的ＣＯＳ７细胞提取ＲＮＡ进行狭缝杂交分析和免疫细胞化学反应,分别从转录及翻译水平上检测ＢＤＮＦ基因在ＣＯＳ７细胞中的表达。实验还证实在ＣＯＳ７细胞中表达的ｈＢＤＮＦ蛋白可分泌至胞外并可促进中脑黑质细胞的发育和生长,具有良好的生物学活性。     

人脑源性神经营养因子cDNA在COS7细胞中的表达及活性…

本文从质粒Ｍ１３ｍｐ１８－ｈＢＤＮＦ中酶切回收入及源性神经营养因子（ｈＢＤＮＦ）全长基因,构建真核表达载体ｐＣＭＶ４－ｈＢＤＮＦ。利用脂质体的方法转染ＣＯＳ７细胞,对转染后的ＣＯＳ７细胞提取ＲＮＡ进行狭缝杂交分析和免疫细胞化学反应,分别从转录及翻译水平上检测ＢＤＮＦ基因在ＣＯＳ７细胞中的表达。实验还证实在ＣＯＳ７细胞中表达的ｈＢＤＦ蛋白可分泌至胞外并可促进中脑黑质细胞的发育和生长,具有良好的生物学     

酰化人红细胞超氧化物歧化酶稳定性的研究

用月桂酸对人红细胞超氧化物歧化酶进行化学修饰处到酰化ｈ－ＳＯＤ,并对Ａｃ－ｈＳＯＤ和ｈ－ＳＯＤ的稳定性进行了比较。结果表明：Ａｃ－ｈＳＯＤ活力为ｈ－ＳＯＤ的７２％,比活力为４０００Ｕ／ｍｇ,Ａｃ－ｈＳＯＤ的热稳定性,酸碱稳定性及抗蛋白酶水解能力均比天然酶提高。     

硫代反义寡核苷酸在细胞培养内抗甲型流感病毒活性

为了研究抗流感病毒特异性反义核酸药物,针对Ａ型流感病毒基因组３＇和５＇端保守序列,设计并合成了４条硫代寡核苷酸（ＯＤＮ）：３＇端反义ＯＤＮ（ＩＶ３＾＃）与３＇端正义ＯＤＮ（ＩＶ３Ｓ）,５＇端反义ＯＤＮ（ＩＶ４＾＃）与５＇端正交ＯＤＮ（ＩＶ４Ｓ）。以流感病毒血凝滴度和致细胞病变作用为指标,测定了ＯＤＮｓ在ＭＤＣＫ细胞中对Ａ型流感病毒Ａ／京防／８６－１（Ｈ１Ｎ１）复制的影响。结果表明,与流感病毒基因组     

虎斑颈槽蛇胸腺APUD细胞的免疫组织化学观察

虎斑颈槽蛇胸腺ＡＰＵＤ细胞的免疫组织化学观察ＴＨＥＩＭＭＵＮＯＨＩＳＴＯＣＨＥＭＩＣＡＬＯＢＳＥＲＶＡＴＩＯＮＯＦＴＨＥＴＨＹＭＩＣＡＰＵＤＣＥＬＬＳＩＮＴＨＥＳＮＡＫＥＲＨＡＢＤＯＰＨＩＳＴＩＧＲＩＮＡＫｅｙｗｏｒｄｓＲｈａｄｂｄｏｐｈｉｓｔｉｇｒ...     

氧化修饰使HDL促动脉平滑肌细胞胆固醇流出减少

为了研究氧化修饰对高密度脂蛋白（ＨＤＬ）转运细胞胆固醇地＾３Ｈ－胆固醇负荷的培养人动脉平滑肌细胞（ＳＭＣ）分别与天然ＨＤＬ及Ｃｕ＾２＋ａｋｇ ＨＯＣｌ氧化修饰的ＨＤＬ在３７℃温育不同时间后,分别测定细胞＾３Ｈ－胆固醇清除率。结果发现,温育２４ｈ后,经Ｃｕ＾２＋或ＨＯＬｌ氧修饰后的ＨＤＬ其细胞胆因醇清除率分别较天然ＨＤＬ下降了３０．０％和４３．１％（ｐ〈０．０１）。结果还发现,Ｃｕ＾２＋或ＨＯＣｌ氧     

修饰和导入技术对于反义寡核苷酸的影响

合成了３′末端三个磷酸二酯键硫代修饰的针对ＤＮＡ聚合酶α的反义核苷酸ＡＳα,利用［３Ｈ］ＴｄＲ参入方法测定了ＡＳα对于ＨｅＬａ细胞ＤＮＡ复制的抑制效力。结果表明,这种修饰明显增强了寡核苷酸在含血清的细胞培养液中的稳定性。Ｌｉｐｏｆｅｃｔｉｎ能够促进ＡＳα的入胞并且增强其抑制效力。ＤＥＡＥＤｅｘｔｒａｎ也能提高ＡＳα的效力     

决明组织培养的研究

以草决明无菌苗子叶为外植体,接种于７类诱导愈伤组织的培养基上：Ａ．ＭＳ＋２．０２,４－Ｄｍｇ／Ｌ（以下单位省略）＋０．３ＢＡ＋０．２ＮＡＡ．Ｂ．ＭＳ＋０．２２,４－Ｄ十０．２ＢＡ＋２．０ＮＡＡ．Ｃ．ＭＳ＋１．０２,４－Ｄ＋０．５ＢＡ＋０．２ＫＴ．Ｄ．ＭＳ＋０．７ＢＡ＋１．５ＮＡＡ＋０．１ＫＴ．Ｅ．ＭＳ＋１．５２,４－Ｄ＋０．７ＢＡ十０．２ＭＡＡ．Ｆ．ＭＳ＋０．４２．４－Ｄ＋１．０ＮＡＡ＋０．１ＫＴ．Ｇ．ＭＳＢ（ＭＳ的无机成份和Ｂ５有机成分）＋０．１５ＮＡＡ＋ＢＡ,ＫＴ和ＺＴ各０．５。８～１５天后分别有９０～９９．６％的子叶片被诱导出愈伤组织,并且Ｆ．与Ｃ．类培养基对诱导愈伤组织比较理想,放于Ｇ培养基上的愈伤组织有９．２～３０．２％的芽分化率。芽在生根培养基１／２ＭＳ＋０．２ＩＢＡ中、９８％生根,形成完整的再生植株。     

应用放射性自显影技术检测外源DNA与鸡精子的结合

应用放射性自显影技术检测外源ＤＮＡ与鸡精子的结合ＤＥＴＥＣＴＩＮＧＡＳＳＯＣＩＡＴＩＯＮＯＦＥＸＯＧＥＮＯＵＳＤＮＡＷＩＴＨＣＨＩＣＫＥＮＳＰＥＲＭＵＳＩＮＧＡＵＴＯＲＡＤＩＯＧＲＡＰＨＹ关键词鸡，精子，脂质体，ＤＮＡ与精子的结合ＫｅｙｗｏｒｄｓＣｈ...     

酰化人红细胞超氧化物歧化酶稳定性的研究

用月桂酸对人红细胞超氧化物歧化酶（ｈ－ＳＯＤ）进行化学修饰得到酰化ｈ－ＳＯＤ（Ａｃ－ｈＳＯＤ）,并对Ａｃ－ｈＳＯＤ和ｈ－ＳＯＤ的稳定性进行了比较。结果表明：Ａｃ－ｈＳＯＤ活力为ｈ－ＳＯＤ的７２％。比活力为４０００Ｕ／ｍｇ,Ａｃ－ｈＳＯＤ的热稳定性、酸碱稳定性及抗蛋白酶水解能力均比天然酶提高。     

反义寡核苷酸体外抗流感病毒活性

为了获得具有抗流感病毒活性的反义寡核苷酸,针对A型流感病毒基因组3′和5′端保守序列,设计并合成了多条硫代寡核苷酸(ODN)：3′端反义ODN(IV3#)与3′端正义ODN(IV3S);5′端反义ODN(IV4#)与5′端正义ODN(IV4S)以及由5′和3′端正义/反义保守序列组成的复合序列ODN(IV6#和IV7#)。测定了PSODN的体外细胞毒性和在MDCK细胞中对流感病毒复制的影响。结果表明：(1)PSODN浓度高达50μmol/L时对MDCK细胞末表现有毒性作用;(2)与流感病毒基因组5′端互补的ODN IV4#以及由5′和3′端保守序列构成的IV6#ODN和IV7#ODN均具有较高的抗病毒活性;如IV4#ODN浓度为1μmol/L时对流感病毒A/京防/861(H1N1)抑制率近50%,浓度为10μmol/L或更高时抑制率超过70%,且IV4#抑制病毒活性呈现明显的序列和剂量依赖性;(3)IV4#ODN不仅对A型流感病毒H1N1亚型有抑制作用,对H3N2亚型也表现较高的抑制活性;(4)病毒感染复数(MOI)对IV4#ODN抗病毒活性有一定影响,当MOI较低时,IV4#ODN表现的剂量效应关系更加明显。抗流感病毒反义寡核苷核IV4#ODN的发现为进一步研究流感新型药物奠定了实验基础。〖HTH〗关键词〖HTSS〗：流感病毒, 反义寡核苷酸, 体外细胞毒性, 抗病毒活性, 感染复数     

pH敏脂质体对反义寡核苷酸抗流感病毒活性的影响

为了研究具有临床应用前景的 Ａ Ｓ Ｏ Ｄ Ｎ 脂质体转运系统,以临床药用大豆磷脂为主要原料制备了ｐ Ｈ 敏脂质体,并测定了脂质体体外转染活性、ｐ Ｈ 敏特性、细胞毒性和对 Ａ Ｓ Ｏ Ｄ Ｎ 抗流感病毒活性的影响 结果发现,批号为 ９８０５１９０３,９８０５１１０２ 和 ９８０５１２０２ 的脂质体具有较高转染活性,但只有ｌｉｐｏｆｅｃｔｉｎ 转染活性的 １／５０～１／１００当质粒／脂质体（ Ｗ ／ Ｗ ）为 １∶４～１∶８,转染时间为 ３～５ ｈ,质粒量为 ０５ μｇ,转染后 ２４～４８ ｈ 内检测时转染活性最高 脂质体 ９８０５１２０２ 表现明显 ｐ Ｈ值依赖溶解红细胞膜特性,而脂质体 ９８０５１１０２ 和 ９８０５１９０３ 的 ｐ Ｈ 敏特性不明显 脂质体细胞毒性明显降低,如 ９８０５１９０３、９８０５１１０２ 和 ９８０５１２０２ 的毒性分别是 ｌｉｐｏｆｅｃｔｉｎ 毒性的 １／１６、１／８ 和 １／４ｐ Ｈ 敏脂质体 ９８０５１２０２ 具有促进 Ａ Ｓ Ｏ Ｄ Ｎ 抗流感病毒作用,当 Ａ Ｓ Ｏ Ｄ Ｎ 浓度为 ０２ μｍ ｏｌ／ Ｌ 时,ｐ Ｈ 敏脂质体 ９８０５１２０２ 使其抗病毒活性提高 ５ 倍,但 Ａ Ｓ Ｏ Ｄ Ｎ 浓度较高时ｐ Ｈ 敏脂质体对 Ａ Ｓ Ｏ Ｄ Ｎ抗     

Impact of delivery method on antiviral activity of phosphodiester,phosphorothioate, and phosphoryl guanidine oligonucleotides in MDCK cells infected with H5N1 bird flu virus

We have previously described nanocomposites containing conjugates or complexes of native oligodeoxyribonucleotides with poly-L-lysine and TiO₂ nanoparticles. We have shown that these nanocomposites efficiently suppressed influenza A virus reproduction in MDCK cells. Here, we have synthesized previously undescribed nanocomposites that consist of TiO₂ nanoparticles and polylysine conjugates with oligonucleotides that contain phosphoryl guanidine or phosphorothioate internucleotide groups. These nanocomposites have been shown to exhibit antiviral activity in MDCK cells infected with H5N1 influenza A virus. The nanocomposites containing phosphorothioate oligonucleotides inhibited virus replication ~130-fold. More potent inhibition, i.e., ~5000-fold or ~4600-fold, has been demonstrated by nanocomposites that contain phosphoryl guanidine or phosphodiester oligonucleotides, respectively. Free oligonucleotides have been nearly inactive. The antiviral activity of oligonucleotides of all three types, when delivered by Lipofectamine, has been significantly lower compared to the oligonucleotides delivered in the nanocomposites. In the former case, the phosphoryl guanidine oligonucleotide has appeared to be the most efficient; it has inhibited the virus replication by a factor of 400. The results make it possible to consider phosphoryl guanidine oligonucleotides, along with other oligonucleotide derivatives, as potential antiviral agents against H5N1 avian flu virus.     

Inhibition of dengue virus by novel, modified antisense oligonucleotides.

Five different target regions along the length of the dengue virus type 2 genome were compared for inhibition of the virus following intracellular injection of the cognate antisense oligonucleotides and their analogs. Unmodified phosphodiester oligonucleotides as well as the corresponding phosphorothioate oligonucleotides were ineffective in bringing about a significant inhibition of the virus. Novel modified phosphorothioate oligonucleotides in which the C-5 atoms of uridines and cytidines were replaced by propynyl groups caused a significant inhibition of the virus. Antisense oligonucleotide directed against the target region near the translation initiation site of dengue virus RNA was the most effective, followed by antisense oligonucleotide directed against a target in the 3' untranslated region of the virus RNA. It is suggested that the inhibitory effect of these novel modified oligonucleotides is due to their increased affinity for the target sequences and that they probably function via an RNase H cleavage of the oligonucleotide:RNA heteroduplex.     

In vitro anti-HIV activity of phosphorothioate alpha-anomeric oligodeoxynucleotides

Oligonucleotide analogs consisting exclusively of alpha-anomeric deoxynucleoside units bridged with phosphorothioate linkages have been synthesized and tested in vitro as antiviral agents against human immunodeficiency virus (HIV) in human T cells. Two 28-mers, an homopolymer alpha-S-dC28 and an oligomer alpha-S-anti-rev complementary to the initiation site of the regulatory viral gene rev exhibited antiviral activities comparable to those reported for the corresponding beta-anomeric phosphorothioate analogs. In contrast, a nuclease-resistant homopolymer, alpha-dC28 was inactive. Their preliminary results would indicate that the origin of oligonucleotide phosphorothioate anti-HIV activity is not exclusively correlated with their higher nuclease resistance.     

反义寡核苷酸药物癌泰得的定性分析方法研究

 癌泰得 (ACTCACTCAGGCCTCAGACT)为端粒酶表达抑制活性反义寡核苷酸 .为了探讨其定性检测手段 ,通过阴离子交换高效液相色谱和毛细管凝胶电泳分析方法 ,确定了该硫代寡核苷酸以及与其有关的短序列和部分未被硫代类似物的保留时间 ,并分析了不同混合物样品 .结果表明 ,阴离子交换高效液相色谱对硫代寡核苷酸骨架上的差异非常敏感 ,可很好地分离长度相同的硫代和未完全硫代类似物 ,并且随未被硫代磷酸基数目增加 ,保留时间依次缩短 .阴离子交换高效液相色谱对硫代寡核苷酸的长度不敏感 ,不能分离相差一个碱基的硫代寡核苷酸 .毛细管凝胶电泳可很好地分离长度相差一个碱基的硫代寡核苷酸 ,不能分离同长硫代和部分硫代寡核苷酸 .高效液相色谱结合毛细管凝胶电泳可有效地确定癌泰得的纯度和修饰程度 .     

Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs

An oligonucleotide with a dimeric hairpin guanosine quadruplex (basket type structure) (dG3T4G3-s), containing phosphorothioate groups, was able to inhibit human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and virus production (as measured by p24 core antigen expression) in peripheral blood mononuclear cells. This oligonucleotide lacks primary sequence homology with the complementary (antisense) sequences to the HIV-1 genome. Furthermore, this oligonucleotide may have increased nuclease resistance. The activity of this oligonucleotide was increased when the phosphodiester backbone was replaced with a phosphorothioate backbone. In vivo results showed that dG3T4G3-s was capable of blocking the interaction between gp120 and CD4. We also found that dG3T4G3-s specifically inhibits the entry of T-cell line-tropic HIV-1 into cells. This compound is a viable candidate for evaluation as a therapeutic agent against HIV-1 in humans.     

Synthesis and properties of modified oligonucleotides.

Phosphorothioate oligonucleotide analogs conjugated to cholesteryl by a neutral, 6 atom linker are more effective inhibitors of HIV-1 in cell culture than the corresponding analogs conjugated via a phosphorothioate group. The antiviral activity correlates with the hydrophobic character of the oligonucleotide. Some new synthetic methodology is also discussed.     

A competitive enzyme hybridization assay for plasma determination of phosphodiester and phosphorothioate antisense oligonucleotides.

An enzyme competitive hybridization assay was developed and validated for determination of mouse plasma concentrations of a 15mer antisense phosphodiester oligodeoxyribonucleotide and of two phosphorothioate analogs. Assays were performed in 96-well microtiter plates. The phosphodiester sense sequence was covalently bound to the microwells. The 5'-biotinylated antisense sequence was used as tracer. The principle of the assay involves competitive hybridization of tracer and antisense nucleotide to the solid phase-immobilized sense oligonucleotide. Solid phase- bound tracer oligonucleotide was assayed after reaction with a streptavidin-acetylcholinesterase conjugate, using the colorimetric method of Ellman. As in competitive enzyme immunoassays, coloration was inversely related to the amount of analyte initially present in the sample. The limit of quantification was 900 pM for phosphodiester antisense oligonucleotide using a 100 microl volume of plasma without extraction. Cross-reactivity was negligible after a four base deletion in either the 3'or 5'position. The assay was simple and sensitive, suitable for in vitro screening of oligonucleotide hybridization potency in biological fluids and for measuring the plasma pharmacokinetics of phosphorothioate and phosphodiester sequences.     

Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides

Lipofectin, which is a mixture of neutral lipid with a cationic lipid, has been widely used to enhance cellular delivery of phosphorothioate, 2'-sugar-modified, and chimeric antisense oligonucleotides. Phosphodiester oligonucleotides delivered with Lipofectin usually do not elicit antisense activity probably because cationic lipid formulations do not sufficiently protect unmodified oligonucleotides from nuclease degradation. We show that a cationic polymer, polyethylenimine (PEI), improves the uptake and antisense activity of 3'-capped 20-mer and 12-mer antisense phosphodiester oligonucleotides (PO-ODN) targeted to different regions of Ha-ras mRNA and to the 3'-untranslated region (3'-UTR) of C-raf kinase. In contrast, PEI, which forms a very stable complex with the 20-mer phosphorothioate oligonucleotide (PS-ODN), does not enhance its antisense activity. Using fluorescently labeled carriers and ODN, we show that PEI-PS-ODN particles are very efficiently taken up by cells but PS-ODN is not dissociated from the carrier. Our results indicate that carrier-ODN particle size and stability and ODN release kinetics vary with the chemical nature of the ODN and the carrier being transfected into the cells. The very low cost of PEI compared with cytofectins and the increased affinity for target mRNA and decreased affinity for proteins of PO-ODN compared with PS-ODN make the use of PEI-PO-ODN very attractive.